• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏液型与非黏液型感染的抗生素药敏模式和临床特征的对比分析:一项回顾性研究。

Comparative analysis of antibiotic susceptibility patterns and clinical features of mucoid and non-mucoid infections: a retrospective study.

机构信息

Medical Laboratory Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.

General Medicine, Clinical Medicine, Kangda College of Nanjing Medical University, Lianyungang, Jiangsu, China.

出版信息

Front Public Health. 2024 Feb 8;12:1333477. doi: 10.3389/fpubh.2024.1333477. eCollection 2024.

DOI:10.3389/fpubh.2024.1333477
PMID:38389944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10881668/
Abstract

BACKGROUND

(PA) is a prevalent opportunistic pathogen that has close associations with both acute and chronic infections. However, there exists an insufficiency of accurate and comprehensive data pertaining to the antimicrobial susceptibility patterns and clinical characteristics of both mucoid and non-mucoid strains of PA (mPA and non-mPA, respectively).

METHODS

From January 1, 2021 to December 31, 2022, a thorough retrospective study was carried out to examine and compare the antibiotic susceptibility test outcomes and clinical characteristics of hospitalized patients with mPA and non-mPA infections.

RESULTS

This study investigated a cohort of 111 patients who were diagnosed with mPA infections, as well as 792 patients diagnosed with non-mPA infections. Significant demographic disparities, including gender ( < 0.001), age ( < 0.001), length of hospital stay ( < 0.001), diabetes ( = 0.043), and hypertension ( < 0.001), are evident between the mPA and non-mPA groups. The mPA group commonly necessitates hospitalization for respiratory system diseases, whereas the non-mPA group is associated with concomitant cardiovascular and cerebrovascular diseases. The mPA group demonstrates lower utilization rates of medical devices, such as Foley catheter ( < 0.001), nasogastric tube ( < 0.001), mechanical ventilation ( < 0.001), tracheostomy ( < 0.001), arterial and venous catheterization ( < 0.001), and exhibits superior organ function status, including lower incidences of hypoalbuminemia ( < 0.001), septic shock ( < 0.001), liver dysfunction ( < 0.001), renal failure ( < 0.001), and respiratory failure ( < 0.001). The non-mPA group is more vulnerable to infection with two or more bacterial pathogens compared to the mPA group, with the non-mPA group frequently resulting in Enterobacteriaceae infections and the mPA group being associated with fungal infections. Variations in antibiotic sensitivity are noted for Amikacin ( < 0.001), Ciprofloxacin ( < 0.001), Cefepime ( = 0.003), and Levofloxacin ( < 0.001) in antibiotic susceptibility testing, with resistance patterns closely tied to specific antibiotic usage.

CONCLUSION

There are significant demographic characteristics, clinical manifestations and antibiotic susceptibility between mPA and non-mPA infections. It is crucial to emphasize these characteristics due to their significant role in preventing and treating PA infections.

摘要

背景

(PA)是一种普遍存在的机会性病原体,与急性和慢性感染都有密切关联。然而,目前关于粘液化和非粘液化 PA(mPA 和非-mPA,分别)的药敏模式和临床特征的准确、全面的数据仍然不足。

方法

本研究于 2021 年 1 月 1 日至 2022 年 12 月 31 日进行了一项全面的回顾性研究,以检查和比较住院患者 mPA 和非-mPA 感染的抗生素敏感性试验结果和临床特征。

结果

本研究共调查了 111 例 mPA 感染患者和 792 例非-mPA 感染患者。两组患者在性别(<0.001)、年龄(<0.001)、住院时间(<0.001)、糖尿病(=0.043)和高血压(<0.001)等方面存在显著的人口统计学差异。mPA 组常见的住院治疗原因是呼吸系统疾病,而非-mPA 组则与心血管和脑血管疾病并存。mPA 组中 Foley 导管(<0.001)、鼻胃管(<0.001)、机械通气(<0.001)、气管切开术(<0.001)、动静脉置管(<0.001)等医疗器械的使用率较低,器官功能状态较好,低白蛋白血症(<0.001)、感染性休克(<0.001)、肝功能障碍(<0.001)、肾功能衰竭(<0.001)和呼吸衰竭(<0.001)的发生率较低。与 mPA 组相比,非-mPA 组更容易感染两种或两种以上的细菌病原体,非-mPA 组常导致肠杆菌科感染,而 mPA 组与真菌感染有关。在抗生素敏感性试验中,阿米卡星(<0.001)、环丙沙星(<0.001)、头孢吡肟(=0.003)和左氧氟沙星(<0.001)的抗生素敏感性存在差异,耐药模式与特定抗生素的使用密切相关。

结论

mPA 和非-mPA 感染之间存在显著的人口统计学特征、临床表现和抗生素敏感性。由于这些特征在预防和治疗 PA 感染方面具有重要作用,因此必须强调这些特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8023/10881668/76f947b7cb58/fpubh-12-1333477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8023/10881668/76f947b7cb58/fpubh-12-1333477-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8023/10881668/76f947b7cb58/fpubh-12-1333477-g001.jpg

相似文献

1
Comparative analysis of antibiotic susceptibility patterns and clinical features of mucoid and non-mucoid infections: a retrospective study.黏液型与非黏液型感染的抗生素药敏模式和临床特征的对比分析:一项回顾性研究。
Front Public Health. 2024 Feb 8;12:1333477. doi: 10.3389/fpubh.2024.1333477. eCollection 2024.
2
Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.土耳其马拉蒂亚市一家大学医院铜绿假单胞菌感染的临床、微生物学和流行病学特征
Am J Infect Control. 2006 May;34(4):188-92. doi: 10.1016/j.ajic.2005.11.010.
3
Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.三级转诊中心铜绿假单胞菌与恶臭假单胞菌角膜炎的临床特征及抗生素敏感性比较:一项回顾性研究
BMC Ophthalmol. 2018 Aug 20;18(1):204. doi: 10.1186/s12886-018-0882-3.
4
Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type.铜绿假单胞菌黏液型和非黏液型的流行率及抗菌药敏性
Southeast Asian J Trop Med Public Health. 2004 Dec;35(4):893-6.
5
Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.接受依伐卡托治疗的携带c.1652G›A(G551D)-CFTR的囊性纤维化患者中的铜绿假单胞菌——微生物学参数的变化
J Clin Pharm Ther. 2018 Feb;43(1):92-100. doi: 10.1111/jcpt.12616. Epub 2017 Sep 22.
6
[A control study on bacterial resistance and clinical features of lower respiratory tract infection with Pseudomonas aeruginosa in medical intensive care unit and general ward].[重症医学科与普通病房铜绿假单胞菌下呼吸道感染细菌耐药性及临床特征的对照研究]
Zhonghua Nei Ke Za Zhi. 2002 Dec;41(12):813-7.
7
The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients.多重耐药铜绿假单胞菌感染对急性胰腺炎患者的影响。
BMC Infect Dis. 2023 May 22;23(1):340. doi: 10.1186/s12879-023-08230-y.
8
Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.依伐卡托是否会干扰常用抗生素对铜绿假单胞菌的抗菌活性?——一项体外研究的结果。
J Clin Pharm Ther. 2018 Dec;43(6):836-843. doi: 10.1111/jcpt.12722. Epub 2018 Jun 29.
9
Comparative study of the biological characteristics of mucoid and non-mucoid Pseudomonas aeruginosa strains isolated from chronic respiratory infections.从慢性呼吸道感染中分离出的黏液型和非黏液型铜绿假单胞菌菌株生物学特性的比较研究
Arch Roum Pathol Exp Microbiol. 1989 Jul-Sep;48(3):193-207.
10
Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study.埃塞俄比亚东北部德西综合专科医院住院患者中不动杆菌和铜绿假单胞菌医院感染的耐药谱及相关因素。一项横断面研究。
PLoS One. 2021 Nov 15;16(11):e0257272. doi: 10.1371/journal.pone.0257272. eCollection 2021.

引用本文的文献

1
Development and Validation of a Nomogram for Predicting Multidrug-Resistant Pneumonia in Hospitalized Patients.用于预测住院患者多重耐药性肺炎的列线图的开发与验证
Infect Drug Resist. 2025 Jul 16;18:3543-3559. doi: 10.2147/IDR.S527949. eCollection 2025.
2
Unveiling the molecular epidemiology of Pseudomonas aeruginosa in lung infections among cystic fibrosis patients in the Brazilian Amazon.揭示巴西亚马逊地区囊性纤维化患者肺部感染中铜绿假单胞菌的分子流行病学。
BMC Microbiol. 2025 Apr 9;25(1):203. doi: 10.1186/s12866-025-03920-w.
3
Clinical Ramifications of Bacterial Aggregation in Pleural Fluid.

本文引用的文献

1
Attenuation of biofilm and quorum sensing regulated virulence factors of an opportunistic pathogen Pseudomonas aeruginosa by phytofabricated silver nanoparticles.植物源银纳米粒子对机会性病原体铜绿假单胞菌生物膜和群体感应调控毒力因子的衰减作用。
Microb Pathog. 2023 Dec;185:106433. doi: 10.1016/j.micpath.2023.106433. Epub 2023 Oct 31.
2
Editorial: Emerging multidrug-resistant bacterial pathogens "superbugs": A rising public health threat.社论:新出现的多重耐药性细菌病原体“超级细菌”:对公众健康的威胁日益增加。
Front Microbiol. 2023 Feb 1;14:1135614. doi: 10.3389/fmicb.2023.1135614. eCollection 2023.
3
Relationship between Biofilm-Formation, Phenotypic Virulence Factors and Antibiotic Resistance in Environmental Pseudomonas aeruginosa.
胸腔积液中细菌聚集的临床影响
Infect Dis Rep. 2024 Jul 18;16(4):608-614. doi: 10.3390/idr16040046.
环境中铜绿假单胞菌生物膜形成、表型毒力因子与抗生素耐药性之间的关系
Pathogens. 2022 Sep 5;11(9):1015. doi: 10.3390/pathogens11091015.
4
Quorum Quenching: A Drug Discovery Approach Against Pseudomonas aeruginosa.群体感应淬灭:针对铜绿假单胞菌的药物发现方法。
Microbiol Res. 2022 Nov;264:127173. doi: 10.1016/j.micres.2022.127173. Epub 2022 Aug 23.
5
Editorial: Current perspectives on : epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens.社论:关于多重耐药(MDR)病原体的流行病学、毒力及当代应对策略的当前观点
Front Microbiol. 2022 Jul 26;13:975616. doi: 10.3389/fmicb.2022.975616. eCollection 2022.
6
The role of the hypermutator phenotype on the shift from acute to chronic virulence during respiratory infection.高突变表型在呼吸道感染中急性毒力向慢性毒力转变中的作用。
Front Cell Infect Microbiol. 2022 Jul 22;12:943346. doi: 10.3389/fcimb.2022.943346. eCollection 2022.
7
Virulence Factors of and Antivirulence Strategies to Combat Its Drug Resistance.铜绿假单胞菌的毒力因子与抗其耐药性的抗毒力策略。
Front Cell Infect Microbiol. 2022 Jul 6;12:926758. doi: 10.3389/fcimb.2022.926758. eCollection 2022.
8
Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.铜绿假单胞菌:发病机制、毒力因子、抗生素耐药性、与宿主的相互作用、技术进展和新兴治疗方法。
Signal Transduct Target Ther. 2022 Jun 25;7(1):199. doi: 10.1038/s41392-022-01056-1.
9
The structure-function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment.铜绿假单胞菌在感染中的结构-功能关系及其对微环境的影响。
FEMS Microbiol Rev. 2022 Sep 2;46(5). doi: 10.1093/femsre/fuac018.
10
Carbapenemase-producing -an emerging challenge.产碳青霉烯酶 - 新出现的挑战。
Emerg Microbes Infect. 2022 Dec;11(1):811-814. doi: 10.1080/22221751.2022.2048972.